Cellebrite DI Ltd
NASDAQ:CLBT
Cellebrite DI Ltd
NASDAQ:CLBT
Price:
11.47 USD
1.5%
Market Closed
Updated:
May 16, 2024
Balance Sheet
Balance Sheet Decomposition
Cellebrite DI Ltd
Cellebrite DI Ltd
| Current Assets | 422.1m |
| Cash & Short-Term Investments | 264.2m |
| Receivables | 82.8m |
| Other Current Assets | 75m |
| Non-Current Assets | 110.8m |
| Long-Term Investments | 28.9m |
| PP&E | 30.2m |
| Intangibles | 37.4m |
| Other Non-Current Assets | 14.4m |
| Current Liabilities | 253.8m |
| Accounts Payable | 53.1m |
| Accrued Liabilities | 5m |
| Other Current Liabilities | 195.7m |
| Non-Current Liabilities | 244.8m |
| Other Non-Current Liabilities | 244.8m |
Balance Sheet
Cellebrite DI Ltd
Cellebrite DI Ltd
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
77
|
129
|
146
|
88
|
190
|
|
| Cash Equivalents |
77
|
129
|
146
|
88
|
190
|
|
| Short-Term Investments |
124
|
109
|
36
|
51
|
75
|
|
| Total Receivables |
47
|
70
|
73
|
86
|
83
|
|
| Accounts Receivables |
47
|
70
|
73
|
86
|
83
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
4
|
5
|
7
|
10
|
10
|
|
| Other Current Assets |
11
|
12
|
12
|
61
|
64
|
|
| Total Current Assets |
262
|
324
|
273
|
296
|
422
|
|
| PP&E Net |
15
|
16
|
17
|
33
|
30
|
|
| PP&E Gross |
15
|
16
|
17
|
33
|
30
|
|
| Accumulated Depreciation |
12
|
17
|
21
|
27
|
33
|
|
| Intangible Assets |
0
|
7
|
11
|
11
|
11
|
|
| Goodwill |
0
|
10
|
27
|
27
|
27
|
|
| Long-Term Investments |
0
|
0
|
0
|
22
|
29
|
|
| Other Long-Term Assets |
4
|
8
|
12
|
14
|
14
|
|
| Other Assets |
0
|
10
|
27
|
27
|
27
|
|
| Total Assets |
280
N/A
|
364
+30%
|
340
-7%
|
403
+19%
|
533
+32%
|
|
| Liabilities | ||||||
| Accounts Payable |
5
|
5
|
10
|
5
|
53
|
|
| Accrued Liabilities |
22
|
39
|
43
|
45
|
45
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
72
|
116
|
135
|
158
|
200
|
|
| Total Current Liabilities |
99
|
159
|
187
|
208
|
254
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
21
|
40
|
227
|
122
|
245
|
|
| Total Liabilities |
120
N/A
|
199
+66%
|
413
+107%
|
329
-20%
|
499
+51%
|
|
| Equity | ||||||
| Common Stock |
101
|
101
|
0
|
0
|
0
|
|
| Retained Earnings |
33
|
28
|
78
|
199
|
118
|
|
| Additional Paid In Capital |
26
|
34
|
153
|
126
|
85
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
1
|
1
|
0
|
1
|
|
| Total Equity |
160
N/A
|
165
+3%
|
73
N/A
|
74
N/A
|
34
-54%
|
|
| Total Liabilities & Equity |
280
N/A
|
364
+30%
|
340
-7%
|
403
+19%
|
533
+32%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
189
|
189
|
189
|
193
|
203
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
